Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling

Bo Feng1, Zhihua Li, Jia Bei Wang

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.

Molecular Pharmacology
|January 8, 2011
PubMed

Insights

Protein kinase C (PKC) phosphorylates the μ opioid receptor (MOPr) at Ser363, a key step in regulating MOPr signaling and desensitization. This specific phosphorylation site impacts receptor desensitization at the G protein coupling level.

Area of Science:

  • Biochemistry
  • Molecular Pharmacology
  • Cell Signaling

Background:

  • Opioid receptor signaling is crucial for pain management and other physiological processes.
  • G protein-coupled receptor kinases (GRKs) are known regulators of μ opioid receptor (MOPr) phosphorylation and desensitization.
  • The role of other kinases, such as protein kinase C (PKC), in MOPr regulation remains less understood.

Purpose of the Study:

  • To investigate the specific mechanisms and consequences of PKC-mediated phosphorylation of the MOPr.
  • To identify the precise site of PKC phosphorylation on the MOPr.
  • To determine the functional impact of this phosphorylation on MOPr signaling and desensitization.

Main Methods:

  • In vitro kinase assays using purified PKC and MOPr C-terminal peptides.
  • Protein mass spectrometry to identify phosphorylation sites.
  • Site-directed mutagenesis to create specific MOPr mutants (e.g., S363A).
  • Cell-based assays in Chinese hamster ovary (CHO) cells expressing MOPr, including ligand binding, G-protein coupling assays, and Western blotting with phospho-specific antibodies.

Main Results:

  • PKC directly phosphorylates the MOPr C terminus in vitro.
  • Serine 363 (Ser363) was identified as the primary PKC phosphorylation site on MOPr.
  • Mutation of Ser363 to alanine (S363A) did not alter MOPr ligand binding affinity or basal G protein coupling efficiency.
  • The S363A mutation significantly attenuated phorbol 12-myristate-induced desensitization of MOPr G protein coupling.

Conclusions:

  • PKC phosphorylates MOPr at Ser363, representing a novel regulatory pathway.
  • PKC-mediated phosphorylation of MOPr at Ser363 is critical for agonist-induced desensitization of G protein coupling.
  • This finding elucidates a specific molecular mechanism by which PKC modulates opioid receptor function.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...